Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 5/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | USP14 | P54578 | 3/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | UBE2M | P61081 | 1/20 | 0.32 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | JAK3 | P52333 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12722017 | 1.00 | RORC (0.36) | RORCKDM4EATML3MBTL1PGR | |
| SCHEMBL12722027 | 0.99 | RORC (0.37) | RORCKDM4EATML3MBTL1PGR | |
| SCHEMBL12721741 | 0.96 | PTGDR2 (0.35) | RORCKDM4EPGRPTGDR2TP53 | |
| SCHEMBL13249709 | 0.96 | PGR (0.36) | RORCKDM4EPGRPTGDR2TP53 | |
| SCHEMBL12721857 | 0.95 | PTGDR2 (0.36) | RORCKDM4EPGRPTGDR2TP53 | |
| SCHEMBL12721976 | 0.94 | RORC (0.40) | RORCKDM4EATML3MBTL1USP14 | |
| SCHEMBL17463228 | 0.92 | KDM4E (0.41) | RORCKDM4EATML3MBTL1USP14 | |
| SCHEMBL12721986 | 0.92 | KDM4E (0.41) | KDM4EATML3MBTL1PTGDR2USP14 | |
| SCHEMBL12722006 | 0.92 | KDM4E (0.41) | KDM4EATML3MBTL1PTGDR2USP14 | |
| SCHEMBL12721902 | 0.91 | PIK3CD (0.35) | RORCKDM4EPGRPTGDR2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7927719-B2 | Silanylamine-based compound, method of preparing the same and organic light emitting device including organic layer comprising the silanylamine-based compound | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2011-04-19 | — | — | US | disclosed |
| US-20080106188-A1 | SILANYLAMINE-BASED COMPOUND, METHOD OF PREPARING THE SAME AND ORGANIC LIGHT EMITTING DEVICE INCLUDING ORGANIC LAYER COMPRISING THE SILANYLAMINE-BASED COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2008-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080106188-A1 | SILANYLAMINE-BASED COMPOUND, METHOD OF PREPARING THE SAME AND ORGANIC LIGHT EMITTING DEVICE INCLUDING ORGANIC LAYER COMPRISING THE SILANYLAMINE-BASED COMPOUND | ICMT, SLC43A1, SLC7A5 | RORC 1851/4885KDM4E 2673/4885ATM 4190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.